Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.190
-0.070 (-3.10%)
At close: Apr 1, 2026, 4:00 PM EDT
2.200
+0.010 (0.46%)
After-hours: Apr 1, 2026, 7:38 PM EDT
Century Therapeutics Revenue
In the year 2025, Century Therapeutics had annual revenue of $109.16M with 1,556.76% growth.
Revenue (ttm)
$109.16M
Revenue Growth
+1,556.76%
P/S Ratio
3.61
Revenue / Employee
$1,399,538
Employees
78
Market Cap
393.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.16M | 102.58M | 1,556.76% |
| Dec 31, 2024 | 6.59M | 4.35M | 194.81% |
| Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
| Dec 31, 2022 | 5.20M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 170.16M |
| Enanta Pharmaceuticals | 66.98M |
| XOMA Royalty | 52.15M |
| X4 Pharmaceuticals | 35.11M |
| Lineage Cell Therapeutics | 14.56M |
| PureTech Health | 6.39M |
IPSC News
- 5 weeks ago - Century Therapeutics to Participate in Upcoming Investor Conferences in March - GlobeNewsWire
- 6 weeks ago - IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewsWire
- 7 weeks ago - Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
- 4 months ago - Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes - GlobeNewsWire
- 6 months ago - Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 7 months ago - Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire